Planning and Evaluation

规划与评估 摘要 新墨西哥州大学癌症中心（UNMCC）已经进行了积极主动和非常深思熟虑的 内部规划和评价进程，最终征聘了新的高级领导人， 在本赠款期内，重新组织和调整联合国赔偿委员会的研究方案。后 2010年2月，NCI对联合国赔偿委员会进行了实地访问，并收到了咨询小组的详细审查， 和研究项目领导人启动了战略规划过程。三个中心范围内的撤退安全 来自癌症中心成员的关键投入。* 每月定期举行联合国赔偿委员会高级领导会议 小组，以及与UNCC研究计划，临床工作 小组和共享资源被用来获得多方面的投入，完善想法并实施最终的 计划这些会议的一个重要成果是确定了征聘高级行政人员的关键领域， 在癌症控制和预防、转化研究、药物开发和早期诊断方面具有专业知识的领导者 阶段临床试验。联合国赔偿委员会外部咨询委员会在战略协调方面发挥了关键作用， 通过年度访问和书面反馈，规划和评价活动。根据选管会的建议， 联合国维和行动协调委员会已经成立了一个新的内部咨询委员会，其中包括我们联合体的领导人 机构，新墨西哥州健康科学中心的大学，和我们的社区，以提高战略 随着联合国赔偿委员会的规模和复杂性的增加，联合国儿童基金会的规划和评价活动也在增加。导演系列讲座 利用这一机会征求国际公认专家对联合国赔偿委员会活动的意见。这些特设 外部评估被用来严格评估联合国维和部队研究计划和临床研究 活动继2013年夏季征聘新的高级领导人之后， 利用领导务虚会和与研究项目领导人的特别晚间会议来评估所有 联合国赔偿委员会的结构和职能。最后，提出了一项建议，将联合国赔偿委员会的研究 计划结构从基本和肿瘤为重点的计划到四个全面的计划， 每一个都无缝地从基础研究到临床转化。四个新项目，癌症控制;癌症 遗传学、表观遗传学和基因组学;转化癌症生物学和信号传导;以及癌症治疗： 技术、发现和定向交付随后得到了联合国赔偿委员会东非共同体的认可， 由NCI。新的、更加流动和灵活的结构增加了各组织之间的互动和协调， UNCC研究方案和临床工作组。此外，联合国赔偿委员会试点赠款方案 修改后，以促进新的研究计划的发展和促进转化研究。 最后，制定了一项战略计划，使共享资源能力与不断发展的目标保持一致， UNCC的研究活动，重点是加强以患者为中心的癌症控制 研究活动，解决癌症之间的差异，新墨西哥州的不同，多民族的人口。

PLANNING & EVALUATION ABSTRACT The University of New Mexico Cancer Center (UNMCC) has undergone a proactive and very deliberate internal planning and evaluation process that has culminated in the recruitment of new Senior Leaders and the reorganization and reshaping of the UNMCC Research Programs during the current grant period. Following the NCI Site Visit of the UNMCC in February 2010 and receipt of the detailed CCSG review, UNMCC Leadership and Research Program Leaders initiated a strategic planning process. Three Center-wide retreats secured critical input from Cancer Center members. Regular monthly meetings of the UNMCC Senior Leadership group, as well as leadership meetings with heads of the UNMCC Research Programs, Clinical Working Groups, and Shared Resources, were used to obtain multi-faceted input, refine ideas and implement a final plan. An important outcome of these meetings was the identification of key areas for the recruitment of Senior Leaders with expertise in cancer control and prevention, translational research, drug development and early phase clinical trials. The UNMCC External Advisory Committee (EAC) played a critical role in the strategic planning and evaluation activities through annual visits and written feedback. As recommended by the EAC, the UNMCC has established a new Internal Advisory Committee that includes leaders from our Consortium institutions, the University of New Mexico Health Sciences Center, and our communities, to enhance strategic planning and evaluation activities as the UNMCC increases in size and complexity. A Director's Lecture Series was utilized to garner advice from internationally recognized experts on UNMCC activities. These ad hoc external evaluations were used to critically evaluate the UNMCC Research Programs and clinical research activities. Following the recruitment of new Senior Leaders in the summer of 2013, a series of Senior Leadership retreats and special evening meetings with Research Program leaders were utilized to evaluate all aspects of UNMCC structure and function. This culminated in a proposal to transform the UNMCC Research Program structure from a mix of basic and tumor-focused programs into four comprehensive programs that each seamlessly span basic research to clinical translation. The four new programs, Cancer Control; Cancer Genetics, Epigenetic and Genomics; Translational Cancer Biology and Signaling; and Cancer Therapeutics: Technology, Discovery, & Targeting Delivery, were subsequently endorsed by the UNMCC EAC and approved by the NCI. The new, more fluid and flexible structure has increased interactions and coordination between the UNMCC Research Programs and Clinical Working Groups. In addition, the UNMCC pilot grant program has been modified to foster the development of the new research programs and promote translational research. Finally, a strategic plan has been developed to align Shared Resource capabilities with the evolving goals and research activities of the UNMCC with an emphasis on enhancing patient-centered and cancer control research activities that address cancer disparities among the diverse, multi-ethnic populations of New Mexico.